Nice Insight
Introduction Since 2021, Phenotypeca has been collaborating with Isogenica in an IUK-funded project worth up to £400,000 to design, produce, and test therapeutic antibody fragments. Isogenica ...
Casey Jenkins
Given the ever-expanding volume of drug, disease, and other information that clinicians need to access at the point of care, there is an acute need for a robust and user-friendly interface that ...
Michael Moussourakis
In the pharmaceutical industry, proper critical cleaning, sanitation, and sterilization are essential to avoid biological, chemical, and environmental contamination and to ensure the safety and ...
Kristen M. Eisenhauer, Mark Mintz
Collecting, sharing, and visualizing the huge volumes of data created during the early stages of drug discovery and development have long represented bottlenecks to accessibility and efficiency ...
Mike Fiske
A recent survey of 100 decision makers at innovative biologics companies revealed 57% of respondents believe their companies’ outsourcing activities will increase over the next two years, while ...
Thomas Briel, Ph.D., David Lüdeker, Ph.D.
Poor solubility is a significant and growing issue for the small molecule pharma pipeline. Active pharmaceutical ingredient (API) processing can address API solubility early in drug development. ...
Petrina Kamya, Ph.D.
Across the pharmaceutical industry, companies are finding new ways to leverage artificial intelligence (AI) to accelerate and revolutionize drug discovery and development, clinical trials, and ...
The Pharma’s Almanac editorial team is very excited to present our Q3 digital issue, which features new content from our team and our colleagues at Nice Insight on a range of trending topics and from some truly remarkable subject matter experts from across the pharma/biopharma ecosystem, including drug discovery and development companies, life science industrials, technology providers, consultants, and contract development and manufacturing organizations. The featured articles address topics that span the biopharmaceutical value chain, threaded throughout with reminders to always consider the patient, throughout discovery, formulation, manufacturing, and beyond.
Pharma Service Provider Further Expands Offerings for Clinical Development and Manufacturing
Check out the top 100 articles and trending topics our subscribers are reading right now.
Discover which PA contributors have had the most readers.
Find out which companies have been viewed the most in each industry segment.
View more about the industry-leading companies who contributed to Pharma's Almanac.
View Full Company Directory